Not Yet Recruiting
Clinical Study on the Safety, Efficacy and Pharmacokinetics of Universal CLL1 Chimeric Antigen Receptor T-Cell in Relapsed/Refractory Acute Myeloid Leukemia
NCT07432100
- Conditions
- Acute Myeloid Leukemia, Chimeric Antigen Receptor T-cell, Hematologic Diseases, +7 more
- Locations
-
Not specified